170 related articles for article (PubMed ID: 16492547)
1. Effects on plasma glucose and lactate.
Young A
Adv Pharmacol; 2005; 52():193-208. PubMed ID: 16492547
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
3. Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.
Young AA; Rink TJ; Wang MW
Life Sci; 1993; 52(21):1717-26. PubMed ID: 8502117
[TBL] [Abstract][Full Text] [Related]
4. Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus.
Haynes JM; Hodgson WC; Cooper ME
Diabetologia; 1997 Mar; 40(3):256-61. PubMed ID: 9084962
[TBL] [Abstract][Full Text] [Related]
5. Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology.
Castillo MJ; Scheen AJ; Lefèbvre PJ
Diabete Metab; 1995 Feb; 21(1):3-25. PubMed ID: 7781840
[TBL] [Abstract][Full Text] [Related]
6. Nephrectomy decreases amylin and pramlintide clearance in rats.
Vine W; Smith P; LaChappell R; Blase E; Lumpkin R; Young A
Horm Metab Res; 1998 Aug; 30(8):514-7. PubMed ID: 9761382
[TBL] [Abstract][Full Text] [Related]
7. Effects in liver.
Young A
Adv Pharmacol; 2005; 52():229-34. PubMed ID: 16492549
[TBL] [Abstract][Full Text] [Related]
8. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats.
Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW
Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519
[TBL] [Abstract][Full Text] [Related]
9. [Role of amylin in glucose homeostasis and its perspective use in diabetes management].
Otto-Buczkowska E; Mazur-Dworzecka U; Dworzecki T
Przegl Lek; 2008; 65(3):135-9. PubMed ID: 18624122
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of calcitonin gene-related peptide and amylin on major markers of glucose metabolism in hepatocytes.
Pittner RA
Eur J Pharmacol; 1997 May; 325(2-3):189-97. PubMed ID: 9163566
[TBL] [Abstract][Full Text] [Related]
11. Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity.
Young AA; Wang MW; Gedulin B; Rink TJ; Pittner R; Beaumont K
Metabolism; 1995 Dec; 44(12):1581-9. PubMed ID: 8786728
[TBL] [Abstract][Full Text] [Related]
12. Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes.
Thompson RG; Gottlieb A; Organ K; Koda J; Kisicki J; Kolterman OG
Diabet Med; 1997 Jul; 14(7):547-55. PubMed ID: 9223392
[TBL] [Abstract][Full Text] [Related]
13. 8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo.
Wang MW; Young AA; Rink TJ; Cooper GJ
FEBS Lett; 1991 Oct; 291(2):195-8. PubMed ID: 1936264
[TBL] [Abstract][Full Text] [Related]
14. Different pharmacological characteristics in L6 and C2C12 muscle cells and intact rat skeletal muscle for amylin, CGRP and calcitonin.
Pittner RA; Wolfe-Lopez D; Young AA; Beaumont K
Br J Pharmacol; 1996 Mar; 117(5):847-52. PubMed ID: 8851500
[TBL] [Abstract][Full Text] [Related]
15. Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.
Gingell JJ; Burns ER; Hay DL
Endocrinology; 2014 Jan; 155(1):21-6. PubMed ID: 24169554
[TBL] [Abstract][Full Text] [Related]
16. Amylin regulation of carbohydrate metabolism.
Young A; Pittner R; Gedulin B; Vine W; Rink T
Biochem Soc Trans; 1995 May; 23(2):325-31. PubMed ID: 7672355
[TBL] [Abstract][Full Text] [Related]
17. High affinity amylin binding sites in rat brain.
Beaumont K; Kenney MA; Young AA; Rink TJ
Mol Pharmacol; 1993 Sep; 44(3):493-7. PubMed ID: 8396712
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gastric emptying.
Young A
Adv Pharmacol; 2005; 52():99-121. PubMed ID: 16492543
[TBL] [Abstract][Full Text] [Related]
19. Amylin injection causes elevated plasma lactate and glucose in the rat.
Young AA; Wang MW; Cooper GJ
FEBS Lett; 1991 Oct; 291(1):101-4. PubMed ID: 1682160
[TBL] [Abstract][Full Text] [Related]
20. Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved.
Beaumont K; Pittner RA; Moore CX; Wolfe-Lopez D; Prickett KS; Young AA; Rink TJ
Br J Pharmacol; 1995 Jul; 115(5):713-5. PubMed ID: 8548167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
